Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Lapatinib and Paclitaxel
DRUG
2 trials
Sponsors
University of Michigan Rogel Cancer Center
, Frederick R. Ueland, M.D.
Conditions
Bladder Cancer
Ovarian Cancer
Urothelial Cancer
Phase 1
Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer
Completed
NCT04608409
Frederick R. Ueland, M.D.
Ovarian Cancer
Start: 2021-03-17
End: 2024-05-17
Updated: 2025-06-29
Phase 2
Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer
Withdrawn
NCT01700010
University of Michigan Rogel Cancer Center
Bladder Cancer, Urothelial Cancer
Start: 2012-11-30
End: 2019-01-31
Updated: 2013-01-17
Related Papers
A Phase 1 Dose Escalation of Lapatinib and Paclitaxel in Recurrent Ovarian Cancer
MDPI (MDPI AG)
2026-02-14